Clinical Study

Procalcitonin-Guided Antibiotics after Surgery for Peritonitis: A Randomized Controlled Study

Table 4

Secondary outcome measures.

ProcalcitoninControl value
All
(n = 79)
Subgroup 1 (n = 31)All
(n = 83)
Subgroup 1 (n = 33)AllSubgroup 1

Duration of hospitalization, d10 (5–24)10 (6–24)8 (4–16)10 (6–20)0.1880.809
Reintroduction of antibiotics6 (7.7%)3 (10%)5 (6.1%)1 (3%)0.7620.340
Reoperation24 (30.4%)6 (19.4%)20 (24.1%)7 (21.1%)0.3831.00
Relavage abdominal cavity10 (12.7%)2 (6.5%)7 (8.4%)3 (9.1%)0.4471.00
Rehospitalization5 (6.6%)1 (3.6%)5 (6.1%)2 (6.1%)1.001.00
Positive blood cultures2 (2.5%)03 (3.6%)2 (6.1%)1.000.493
Intra-abdominal abscess14 (17.7%)3 (9.7%)14 (16.9%)3 (9.1%)1.001.00
Wound infection17 (21.5%)7 (22.6%)15 (18.1%)11 (33.3%)0.6940.410
Septic shock4 (5.1%)1 (3.2%)4 (4.8%)3 (9.1%)1.000.614
Anastomotic leakage3 (3.8%)1 (3.2%)3 (3.6%)2 (6.1%)1.001.00
Urinary infection3 (3.8%)2 (6.5%)1 (1.2%)00.3580.231
Pneumonia2 (2.5%)04 (4.8%)3 (9.1%)0.6820.239
Mortality3 (3.8%)3 (9.7%)4 (4.9%)3 (9.4%)1.001.00

Duration of antibiotics and duration of hospitalization are medians with interquartile range (days). All other parameters are numbers with percentages.